×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
CRSP – crispr therapeutics ag - common shares (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
CRSP
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/22
08:02 pm
crsp
CRISPR Therapeutics AG (CRSP) Rises Higher Than Market: Key Facts [Yahoo! Finance]
Low
Report
CRISPR Therapeutics AG (CRSP) Rises Higher Than Market: Key Facts [Yahoo! Finance]
4/22
06:04 am
crsp
CRISPR Therapeutics (CRSP) had its "sell (d-)" rating reaffirmed by Weiss Ratings.
Low
Report
CRISPR Therapeutics (CRSP) had its "sell (d-)" rating reaffirmed by Weiss Ratings.
4/21
02:07 pm
crsp
CRISPR Therapeutics Has Major Catalysts Ahead. Is This Biotech Stock a Screaming Buy? [Yahoo! Finance]
Low
Report
CRISPR Therapeutics Has Major Catalysts Ahead. Is This Biotech Stock a Screaming Buy? [Yahoo! Finance]
4/21
01:59 pm
crsp
CRISPR Therapeutics Has Major Catalysts Ahead. Is This Biotech Stock a Screaming Buy? [Globe and Mail, The (Toronto, Canada)]
Low
Report
CRISPR Therapeutics Has Major Catalysts Ahead. Is This Biotech Stock a Screaming Buy? [Globe and Mail, The (Toronto, Canada)]
4/21
05:28 am
crsp
Assessing CRISPR Therapeutics (CRSP) Valuation After Recent Share Price Performance [Yahoo! Finance]
Medium
Report
Assessing CRISPR Therapeutics (CRSP) Valuation After Recent Share Price Performance [Yahoo! Finance]
4/13
07:25 pm
crsp
CRISPR Therapeutics AG (CRSP) Presents at 25th Annual Needham Virtual Healthcare Conference Transcript [Seeking Alpha]
Low
Report
CRISPR Therapeutics AG (CRSP) Presents at 25th Annual Needham Virtual Healthcare Conference Transcript [Seeking Alpha]
4/8
06:59 am
crsp
This Biotech Has a Pipeline That Could Redefine Its Entire Therapeutic Area [Yahoo! Finance]
Low
Report
This Biotech Has a Pipeline That Could Redefine Its Entire Therapeutic Area [Yahoo! Finance]
4/7
08:00 am
crsp
CRISPR Therapeutics to Present at the 25th Annual Needham Virtual Healthcare Conference
Low
Report
CRISPR Therapeutics to Present at the 25th Annual Needham Virtual Healthcare Conference
Date
Time
Symbol
Company Name
Action
%Chg
2/12/2026
04:30 pm
CRSP
crispr therapeutics ag - common shares
MISS
Report
10.1%
crispr therapeutics ag - common shares
11/10/2025
08:00 am
CRSP
crispr therapeutics ag - common shares
BEAT
Report
-6.2%
crispr therapeutics ag - common shares
8/4/2025
04:15 pm
CRSP
crispr therapeutics ag - common shares
MISS
Report
-7.1%
crispr therapeutics ag - common shares
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
4/21
08:18 am
crsp
Form ARS CRISPR Therapeutics AG For: Dec 31
Medium
Report
Form ARS CRISPR Therapeutics AG For: Dec 31
4/21
08:11 am
crsp
Form DEFA14A CRISPR Therapeutics AG
Medium
Report
Form DEFA14A CRISPR Therapeutics AG
4/21
08:06 am
crsp
Form DEF 14A CRISPR Therapeutics AG For: Jun 04
Medium
Report
Form DEF 14A CRISPR Therapeutics AG For: Jun 04
4/2
04:24 pm
crsp
Form PRE 14A CRISPR Therapeutics AG For: Jun 04
Low
Report
Form PRE 14A CRISPR Therapeutics AG For: Jun 04
3/24
05:38 pm
crsp
Form 4 CRISPR Therapeutics AG For: Mar 20 Filed by: KASINGER JAMES R.
Low
Report
Form 4 CRISPR Therapeutics AG For: Mar 20 Filed by: KASINGER JAMES R.
3/24
05:38 pm
crsp
Form 4 CRISPR Therapeutics AG For: Mar 20 Filed by: Kulkarni Samarth
Low
Report
Form 4 CRISPR Therapeutics AG For: Mar 20 Filed by: Kulkarni Samarth
3/24
05:37 pm
crsp
Form 4 CRISPR Therapeutics AG For: Mar 20 Filed by: Patel Naimish
Low
Report
Form 4 CRISPR Therapeutics AG For: Mar 20 Filed by: Patel Naimish
3/24
05:37 pm
crsp
Form 4 CRISPR Therapeutics AG For: Mar 20 Filed by: Prasad Raju
Low
Report
Form 4 CRISPR Therapeutics AG For: Mar 20 Filed by: Prasad Raju
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
11/19
CRISPR Therapeutics down 4% premarket on initial CTX001 data [Seeking Alpha]
19.1%
2/28 Can CRISPR Therapeutics Double Your Money in 2020? [The Motley Fool] 13.1%
10/28 Q3/2019 9/30/2019 EPS 2.400 ZacksConsensus N/A ActVsEst N/A - N/A 12.5%
8/5 Form 4 CRISPR Therapeutics AG For: Aug 01 Filed by: Ho Tony W 7.5%
2/7 First CRISPR Gene Editing Trial in Cancer Patients Shows Promising Results [The Motley Fool] 6.8%
12/2 Form 4 CRISPR Therapeutics AG For: Dec 01 Filed by: Kulkarni Samarth 6.3%
11/22 Form 8-K CRISPR Therapeutics AG For: Nov 19 6.1%
10/30 Crispr Therapeutics AG (NASDAQ: CRSP) was upgraded by analysts at TheStreet from a "d" rating to a "c" rating. 5.9%
6/6 Form 8-K CRISPR Therapeutics AG For: Jun 06 5.6%
4/24 Form DEF 14A CRISPR Therapeutics AG For: Jun 11 5.5%
2/28 Can CRISPR Therapeutics Double Your Money in 2020? [The Motley Fool] 13.1%
10/28 Q3/2019 9/30/2019 EPS 2.400 ZacksConsensus N/A ActVsEst N/A - N/A 12.5%
8/5 Form 4 CRISPR Therapeutics AG For: Aug 01 Filed by: Ho Tony W 7.5%
2/7 First CRISPR Gene Editing Trial in Cancer Patients Shows Promising Results [The Motley Fool] 6.8%
12/2 Form 4 CRISPR Therapeutics AG For: Dec 01 Filed by: Kulkarni Samarth 6.3%
11/22 Form 8-K CRISPR Therapeutics AG For: Nov 19 6.1%
10/30 Crispr Therapeutics AG (NASDAQ: CRSP) was upgraded by analysts at TheStreet from a "d" rating to a "c" rating. 5.9%
6/6 Form 8-K CRISPR Therapeutics AG For: Jun 06 5.6%
4/24 Form DEF 14A CRISPR Therapeutics AG For: Jun 11 5.5%
TOP News Decliners
11/20
CRISPR Therapeutics Announces Pricing of Public Offering of Common Shares
-10.6%
3/31 Form 8-K CRISPR Therapeutics AG For: Mar 31 -10.4%
8/3 Crispr Therapeutics AG (NASDAQ: CRSP) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. -10.2%
12/27 Form 8-K CRISPR Therapeutics AG For: Dec 27 -7.5%
12/6 Crispr Therapeutics AG (NASDAQ: CRSP) had its "buy" rating re-affirmed by analysts at Wells Fargo & Co. -7.1%
2/21 Crispr Therapeutics AG (NASDAQ: CRSP) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating. -6.5%
10/1 CRISPR Therapeutics to Present at Upcoming Investor Conferences -6.3%
9/25 Is CRISPR Therapeutics a Buy? [The Motley Fool] -5.9%
2/13 Crispr Therapeutics AG (NASDAQ: CRSP) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $72.50 price target on the stock. -5.6%
6/19 Form 4 CRISPR Therapeutics AG For: Jun 17 Filed by: Kulkarni Samarth -5.6%
3/31 Form 8-K CRISPR Therapeutics AG For: Mar 31 -10.4%
8/3 Crispr Therapeutics AG (NASDAQ: CRSP) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. -10.2%
12/27 Form 8-K CRISPR Therapeutics AG For: Dec 27 -7.5%
12/6 Crispr Therapeutics AG (NASDAQ: CRSP) had its "buy" rating re-affirmed by analysts at Wells Fargo & Co. -7.1%
2/21 Crispr Therapeutics AG (NASDAQ: CRSP) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating. -6.5%
10/1 CRISPR Therapeutics to Present at Upcoming Investor Conferences -6.3%
9/25 Is CRISPR Therapeutics a Buy? [The Motley Fool] -5.9%
2/13 Crispr Therapeutics AG (NASDAQ: CRSP) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $72.50 price target on the stock. -5.6%
6/19 Form 4 CRISPR Therapeutics AG For: Jun 17 Filed by: Kulkarni Samarth -5.6%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: